Introduction Up to 32% of patients with esophageal cancer show a pathological complete
response (ypCR) after neoadjuvant therapy. To prevent overtreatment, the indication to …

This is one of a series of statements discussing the use of GI endoscopy in common clinical
situations. The Standards of Practice Committee of the American Society for Gastrointestinal …

Purpose To evaluate the role of endoscopic ultrasonography (EUS) in the initial staging and
follow-up of esophageal cancer on the basis of a review of the published literature. Methods …

Objective: The aim of this study was to perform a meta-analysis on the accuracy of
endoscopic biopsies, EUS, and 18F-FDG PET (-CT) for detecting residual disease after …

Epidemiology of esophageal cancer and esophagogastric junction (EGJ) has deeply
changed for the past two decades with a dramatically increase of adenocarcinoma whereas …

BACKGROUND. The objective of the current study was to assess the staging accuracy and
prognostic role of preoperative endoscopic ultrasound (EUS) and computed tomography …

Background and Aims Accurate determination of residual cancer status after neoadjuvant
chemoradiotherapy (nCRT) for esophageal cancer could assist in selecting the optimal …

Background and Aims Photodynamic therapy (PDT) is a less-invasive salvage treatment
option for local failure at the primary site after chemoradiotherapy (CRT) for esophageal …

This study aims to evaluate the accuracy of endoscopic ultrasound (EUS) in the staging of
esophageal cancer after neoadjuvant chemotherapy (NAC). Articles were searched in …

Background A pathologically complete response (pCR) to neoadjuvant chemoradiotherapy
(nCRT) is seen in 30% of the patients with oesophageal cancer. The aim is to identify patient …